| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | CBT | Common Stock | Award | $0 | +3,130 | +5.1% | $0.000000 | 64,818 | 08 Nov 2024 | Direct | |
| transaction | CBT | Common Stock | Sale | $1,639,688 | -14,191 | -22% | $115.54 | 50,627 | 11 Nov 2024 | Direct | F1 |
| transaction | CBT | Common Stock | Options Exercise | $709,612 | +12,178 | +24% | $58.27 | 62,805 | 11 Nov 2024 | Direct | |
| transaction | CBT | Common Stock | Sale | $1,400,481 | -12,178 | -19% | $115.00 | 50,627 | 11 Nov 2024 | Direct | F2 |
| transaction | CBT | Common Stock | Options Exercise | $619,518 | +8,390 | +17% | $73.84 | 59,017 | 11 Nov 2024 | Direct | |
| transaction | CBT | Common Stock | Sale | $965,014 | -8,390 | -14% | $115.02 | 50,627 | 11 Nov 2024 | Direct | F3 |
| transaction | CBT | Common Stock | Tax liability | $259,180 | -2,303 | -4.5% | $112.54 | 48,324 | 12 Nov 2024 | Direct | |
| holding | CBT | Common Stock | 7,163 | 08 Nov 2024 | Through the Trustee for the Corporation's 401(k) Plan |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | CBT | Employee Stock Option (Right to Buy) | Award | $0 | +9,341 | $0.000000 | 9,341 | 08 Nov 2024 | Common Stock | 9,341 | $114.99 | Direct | F4 | |
| transaction | CBT | Employee Stock Option (Right to Buy) | Options Exercise | $0 | -12,178 | -60% | $0.000000 | 8,119 | 11 Nov 2024 | Common Stock | 12,178 | $58.27 | Direct | F5 |
| transaction | CBT | Employee Stock Option (Right to Buy) | Options Exercise | $0 | -8,390 | -60% | $0.000000 | 5,594 | 11 Nov 2024 | Common Stock | 8,390 | $73.84 | Direct | F6 |
| Id | Content |
|---|---|
| F1 | The price reported is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $115.500 to $115.595, inclusive. The reporting person undertakes to provide to the staff of the Securities and Exchange Commission, the Corporation or any security holder of the Corporation, upon request, full information regarding the number of shares sold at each separate price. |
| F2 | The price reported is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $115.000 to $115.040, inclusive. The reporting person undertakes to provide to the staff of the Securities and Exchange Commission, the Corporation or any security holder of the Corporation, upon request, full information regarding the number of shares sold at each separate price. |
| F3 | The price reported is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $115.000 to $115.325, inclusive. The reporting person undertakes to provide to the staff of the Securities and Exchange Commission, the Corporation or any security holder of the Corporation, upon request, full information regarding the number of shares sold at each separate price. |
| F4 | The option vests over a three year period as follows: 30% on November 8, 2025, 30% on November 8, 2026 and 40% on November 8, 2027. |
| F5 | 20,297 shares were subject to the option. The option vested over a three year period as follows: 30% on November 12, 2022, 30% on November 12, 2023 and 40% on November 12, 2024. |
| F6 | 13,984 shares were subject to the option. The option vested over a three year period as follows: 30% on November 11, 2023, 30% on November 11, 2024 and 40% on November 11, 2025. |